BARBARA STITT: Open Payments
NPI 1790718476 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 26 payments from 10 companies in 2025. Trend: 2023 $144 · 2024 $566 · 2025 $816
Food & beverage: $782Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $175 |
| Regeneron Healthcare Solutions, Inc. | 6 | $137 |
| Boston Scientific Corporation | 1 | $112 |
| Genentech USA, Inc. | 3 | $90 |
| GENZYME CORPORATION | 2 | $67 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $55 |
| Amgen Inc. | 2 | $54 |
| CSL Behring | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: DUPIXENT, AIRSUPRA, WATCHMAN FLX, Xolair, NEFFY, Hizentra, TRELEGY ELLIPTA, TEZSPIRE.
Industry payments across IN — which companies pay providers there.
